These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 32158395)

  • 1. Dexmedetomidine Protects Against Lipopolysaccharide-Induced Acute Kidney Injury by Enhancing Autophagy Through Inhibition of the PI3K/AKT/mTOR Pathway.
    Zhao Y; Feng X; Li B; Sha J; Wang C; Yang T; Cui H; Fan H
    Front Pharmacol; 2020; 11():128. PubMed ID: 32158395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexmedetomidine Enhances Autophagy
    Yang T; Feng X; Zhao Y; Zhang H; Cui H; Wei M; Yang H; Fan H
    Front Pharmacol; 2020; 11():790. PubMed ID: 32670056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexmedetomidine alleviates cisplatin‑induced acute kidney injury by attenuating endoplasmic reticulum stress‑induced apoptosis via the α2AR/PI3K/AKT pathway.
    Chai Y; Zhu K; Li C; Wang X; Shen J; Yong F; Jia H
    Mol Med Rep; 2020 Mar; 21(3):1597-1605. PubMed ID: 32016445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexmedetomidine Alleviates Ischemia/Reperfusion-Associated Acute Kidney Injury by Enhancing Autophagic Activity
    Zhou BY; Yang J; Luo RR; Sun YL; Zhang HT; Yang AX; Zhang GX
    Front Biosci (Landmark Ed); 2023 Dec; 28(12):323. PubMed ID: 38179733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexmedetomidine Alleviates Lipopolysaccharide-Induced Acute Kidney Injury by Inhibiting p75NTR-Mediated Oxidative Stress and Apoptosis.
    Wang Z; Wu J; Hu Z; Luo C; Wang P; Zhang Y; Li H
    Oxid Med Cell Longev; 2020; 2020():5454210. PubMed ID: 33194004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexmedetomidine protects against acute kidney injury through downregulating inflammatory reactions in endotoxemia rats.
    Tan F; Chen Y; Yuan D; Gong C; Li X; Zhou S
    Biomed Rep; 2015 May; 3(3):365-370. PubMed ID: 26137237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexmedetomidine protects against lipopolysaccharide-induced early acute kidney injury by inhibiting the iNOS/NO signaling pathway in rats.
    Chen Y; Luan L; Wang C; Song M; Zhao Y; Yao Y; Yang H; Ma B; Fan H
    Nitric Oxide; 2019 Apr; 85():1-9. PubMed ID: 30659917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexmedetomidine Ameliorates Acute Stress-Induced Kidney Injury by Attenuating Oxidative Stress and Apoptosis through Inhibition of the ROS/JNK Signaling Pathway.
    Chen Y; Feng X; Hu X; Sha J; Li B; Zhang H; Fan H
    Oxid Med Cell Longev; 2018; 2018():4035310. PubMed ID: 30250633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexmedetomidine alleviates lipopolysaccharide-induced acute kidney injury by inhibiting the NLRP3 inflammasome activation via regulating the TLR4/NOX4/NF-κB pathway.
    Yao Y; Hu X; Feng X; Zhao Y; Song M; Wang C; Fan H
    J Cell Biochem; 2019 Oct; 120(10):18509-18523. PubMed ID: 31243816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
    Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
    Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexmedetomidine attenuates lipopolysaccharide-induced renal cell fibrotic phenotypic changes by inhibiting necroinflammation via activating α
    Sun Q; Kamath P; Sun Y; Liang M; Wu L; Chang E; Chen Q; Alam A; Liu Y; Zhao H; Ma D
    Biomed Pharmacother; 2024 May; 174():116462. PubMed ID: 38513598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dexmedetomidine on lipopolysaccharide-induced acute kidney injury in rats and mitochondrial function in cell culture.
    Kiyonaga N; Moriyama T; Kanmura Y
    Biomed Pharmacother; 2020 May; 125():109912. PubMed ID: 32014689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexmedetomidine attenuates ferroptosis by Keap1-Nrf2/HO-1 pathway in LPS-induced acute kidney injury.
    Luo RR; Yang J; Sun YL; Zhou BY; Zhou SX; Zhang GX; Yang AX
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; ():. PubMed ID: 38722344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexmedetomidine prevents septic myocardial dysfunction in rats via activation of α7nAChR and PI3K/Akt- mediated autophagy.
    Yu T; Liu D; Gao M; Yang P; Zhang M; Song F; Zhang X; Liu Y
    Biomed Pharmacother; 2019 Dec; 120():109231. PubMed ID: 31546082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexmedetomidine ameliorates lipopolysaccharide-induced acute kidney injury in rats by inhibiting inflammation and oxidative stress via the GSK-3β/Nrf2 signaling pathway.
    Feng X; Guan W; Zhao Y; Wang C; Song M; Yao Y; Yang T; Fan H
    J Cell Physiol; 2019 Aug; 234(10):18994-19009. PubMed ID: 30919976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexmedetomidine Protects Against Septic Liver Injury by Enhancing Autophagy Through Activation of the AMPK/SIRT1 Signaling Pathway.
    Yu Q; Zou L; Yuan X; Fang F; Xu F
    Front Pharmacol; 2021; 12():658677. PubMed ID: 33981237
    [No Abstract]   [Full Text] [Related]  

  • 17. Dexmedetomidine protects against lipopolysaccharide-induced sepsis-associated acute kidney injury via an α7 nAChR-dependent pathway.
    Kang K; Gao Y; Wang SC; Liu HT; Kong WL; Zhang X; Huang R; Qi ZD; Zheng JB; Qu JD; Liu RJ; Liu YS; Wang HL; Yu KJ
    Biomed Pharmacother; 2018 Oct; 106():210-216. PubMed ID: 29960167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexmedetomidine alleviates pulmonary edema through the epithelial sodium channel (ENaC) via the PI3K/Akt/Nedd4-2 pathway in LPS-induced acute lung injury.
    Jiang Y; Xia M; Xu J; Huang Q; Dai Z; Zhang X
    Immunol Res; 2021 Apr; 69(2):162-175. PubMed ID: 33641076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-κB p65 and MAPK signaling pathways in septic AKI mice.
    Ren Q; Guo F; Tao S; Huang R; Ma L; Fu P
    Biomed Pharmacother; 2020 Feb; 122():109772. PubMed ID: 31918290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexmedetomidine ameliorates lipopolysaccharide-induced acute lung injury by inhibiting the PI3K/Akt/FoxO1 signaling pathway.
    Cui H; Zhang Q
    J Anesth; 2021 Jun; 35(3):394-404. PubMed ID: 33821300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.